Abstract
Northrop Grumman will report second-quarter 2026 results on July 21, 2026, before the market opens (Pre-MKt); investors are watching whether the expected revenue growth can offset margin pressure implied by consensus EBIT and EPS forecasts.
Market Forecast
Consensus projects second-quarter revenue of 10.80 billion US dollars, up 7.32% year over year, with EPS of 6.82, down 0.07% year over year, and EBIT of 1.14 billion US dollars, down 4.21% year over year. No explicit market forecast was found for gross profit margin or net profit margin; however, the pattern of rising revenue and slightly lower EBIT implies modest margin compression relative to last year.
Across the portfolio, execution on funded programs and backlog conversion remains the core revenue driver, with Aeronautics, Mission Systems, Space Systems, and Defense Systems providing multi-program support and stable deliveries. The most promising segment is Aeronautics Systems, which delivered 3.28 billion US dollars last quarter, up 17.00% year over year, supported by higher B-21 volume tied to capacity expansion and a higher production rate.
Last Quarter Review
Northrop Grumman posted first-quarter revenue of 9.88 billion US dollars, a gross profit margin of 19.84%, GAAP net profit attributable to the parent company of 875.00 million US dollars, a net profit margin of 8.86%, and adjusted EPS of 6.14, up 1.32% year over year.
A key financial highlight was operating momentum: EBIT rose to 989.00 million US dollars, up 72.60% year over year, and operating margin expanded to around 10.00%. Main business highlights included Aeronautics Systems revenue of 3.28 billion US dollars, up 17.00% year over year, reflecting increased B-21 activity; Mission Systems delivered 2.86 billion US dollars, Space Systems 2.48 billion US dollars, and Defense Systems 1.90 billion US dollars, partially offset by 642.00 million US dollars of intersegment eliminations.
Current Quarter Outlook
Core programs and expected revenue mechanics
The quarter’s revenue outlook centers on sustained execution across funded programs and the conversion of a large backlog into sales. Consensus revenue of 10.80 billion US dollars, a 7.32% year-over-year increase, aligns with a continuation of first-quarter momentum, with program volumes supported by long-cycle production and integration schedules. While program mix is diverse, the most visible uplift continues to stem from areas where work content and production cadence have stepped up following capacity additions and rate increases observed earlier this year.
The implied combination of higher revenue and slightly lower EBIT suggests margin headwinds that could derive from mix, learning-curve effects on ramping programs, and near-term cost absorption tied to production acceleration. This dynamic is consistent with the pattern seen in the first quarter, where robust top-line and operating income growth coexisted with program-specific investments and ramp costs that can be margin-dilutive before scale efficiencies are realized. The key to upside on the day is whether operating leverage and cost discipline offset those ramp costs enough to stabilize EBIT margin against the year-ago period.
Program delivery cadence and milestone timing will influence quarterly linearity. Revenue sensitivity also hinges on the timing of hardware acceptances and integration milestones in Space and Mission portfolios. Investors will watch for commentary on throughput in major production lines and any adjustments to near-term delivery schedules, because small shifts can have measurable effects on quarterly revenue recognition.
Aeronautics Systems as the fastest-growing opportunity
Aeronautics Systems remains the primary growth engine this quarter, building on a 17.00% year-over-year sales increase last quarter to 3.28 billion US dollars. The first quarter’s performance was tied to increased B-21 volume after an agreement to expand production capacity and raise the production rate, and those actions typically take several quarters to fully flow through the P&L as learning curves improve and supply chains synchronize. For the current quarter, investors expect this segment to continue driving the company’s aggregate revenue growth given its scale and the visibility associated with ramping programs.
The near-term debate is less about demand—funded backlog and program commitments provide strong top-line visibility—and more about the pace of cost normalization as the rate ramp progresses. As Aeronautics scales, the segment’s path toward steadier unit economics can mitigate margin drag at the consolidated level. The cadence of supplier deliveries and on-time integration across the line will be important operating markers; indications of improved first-pass yield and reduced cycle times would support the case for more stable margins into the second half of the year.
There is also potential incremental support from surveillance and autonomy-linked platforms. Recent indications of commitments for up to five MQ-4C Triton aircraft among European allies, if finalized and scheduled, reinforce the longer-term order pipeline for high-altitude, long-endurance ISR platforms. While new awards and long-lead funding typically contribute to revenue over time rather than immediately, the strengthened pipeline underscores the segment’s multi-year growth optionality.
Mission Systems and Space Systems: stable contributors with margin watch-points
Mission Systems and Space Systems together represent a significant portion of the company’s total revenue and serve as steady contributors to quarterly results. Mission Systems demand patterns are relatively balanced across sensors, processing, and secure networking solutions, where execution and delivery timing establish the quarter-to-quarter profile. Last quarter’s 2.86 billion US dollars revenue base provides a stable starting point; the question for the market is whether mix can support margins while volumes expand modestly.
Space Systems at 2.48 billion US dollars last quarter remains central to revenue diversification. The portfolio’s milestone-based revenue and hardware delivery cycles can introduce quarterly variability, but program funding and customer schedules have underpinned a consistent delivery rhythm. The current quarter’s EBIT forecast implies that, despite the expected revenue expansion, consolidated margin could be weighed by program-mix factors, including early-phase cost absorption or nonrecurring engineering activity that precedes later production benefits.
Both segments’ profitability this quarter will likely be most sensitive to mix shifts within sub-portfolios and to cost performance on development and early production lots. Any indication that milestone timing pulled forward—or slipped—versus plan will influence revenue, while commentary on rate efficiency, supply continuity, and cost takeouts will frame margin expectations into the second half.
Defense Systems: execution steadiness and schedule timing
Defense Systems contributed 1.90 billion US dollars in the first quarter and typically exhibits steadier revenue patterns due to the nature of its programs and sustainment work. For the upcoming print, schedule execution and on-time deliveries remain the main determinants of segment revenue. Given consolidated EBIT is expected to be lower year over year, any upside from Defense Systems would most plausibly come from favorable mix and cost execution rather than large incremental revenue.
Investors will look for updates on throughput where manufacturing steps have been re-sequenced or where process improvements could lift productivity as the year progresses. Signals of incremental efficiency gains or lower rework in this segment can, at the margin, contribute to stabilizing consolidated operating income against consensus.
What will move the stock this quarter
The stock’s immediate reaction is likely to be driven by the interplay of top-line outperformance and the margin trajectory relative to expectations. With consensus calling for 7.32% year-over-year revenue growth and a 4.21% year-over-year decline in EBIT, investors will focus on whether consolidated margin holds flat or compresses, and whether management’s commentary supports operating improvement in the back half of the year. A modest beat on revenue accompanied by steady or improving EBIT margin would be viewed favorably.
Free cash flow narratives also matter for sentiment. Recent commentary around increased capital intensity tied to the B-21 ramp and the withdrawal of a prior mid-term cash flow framework has led several firms to refine valuation assumptions. This backdrop elevates the importance of quarterly cash flow detail—working capital usage, inventory build tied to rate increases, and the conversion of earnings into cash. Any indication of improving working capital efficiency or clearer cadence for capital outlays could help rebalance the discussion.
Order momentum and program visibility round out the catalysts. Updates about contract actions, funding profiles, and the timing of long-lead procurements can reinforce multi-year revenue confidence, while any new commitments that clarify production rates or deliveries can support near-term forecasts. Commentary on supply chain stability and first-pass yield on ramping lines will help investors gauge the slope of margin normalization into the second half of 2026.
Analyst Opinions
Bullish opinions dominate the recent coverage set, outnumbering bearish calls, with multiple firms maintaining Buy or Overweight ratings and focusing on solid revenue growth and program execution while acknowledging near-term margin and cash dynamics. RBC Capital’s Kenneth Herbert maintained a Buy rating with a 750.00 US dollars price target, emphasizing support from execution on major programs and the visibility that accompanies the current funded backlog. Susquehanna’s Charles Minervino also reiterated a Buy, setting a 785.00 US dollars target, highlighting growth potential aligned with program ramps and delivery schedules that underpin the year’s revenue expansion.
Morgan Stanley’s Kristine Liwag reiterated an Overweight rating with a 745.00 US dollars target, framing the quarter’s setup as a balance of healthy top-line growth and the near-term investment required to scale production, with a focus on the pace of margin normalization as volumes increase. Citigroup maintained a Buy while adjusting its target to 587.00 US dollars, noting that while valuation work reflects higher capital needs in the near term, the underlying revenue trajectory remains adequately supported by contract execution and backlog conversion.
Across these bullish views, the common threads are clear: the quarter’s revenue is expected to grow at a solid pace, the most prominent production ramp remains on track, and the investment required to reach target production rates is viewed as a near-term margin headwind but a necessary step toward longer-term earnings power. Analysts also point to the portfolio breadth and the cadence of funded work as key mitigants to quarterly variability. On balance, the majority opinion expects a print broadly in line with, or modestly ahead of, top-line expectations, with investor attention centered on the degree of margin stability and any forward-looking clarity on capex phasing and cash conversion into the second half of 2026.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments